Yahoo France Recherche Web

Résultats de recherche

1. www.addextherapeutics.com › en › investorsAddex therapeutics :: Addex Provisional 2024 Half-Year and ...

   www.addextherapeutics.com › en › investors

   • En cache

   19 sept. 2024 · Geneva, Switzerland, September 19, 2024-Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, announced today that its provisional half-year and second quarter net results have increased ...

2. www.addexpharma.com › en › investorsAddex Therapeutics Reports 2024 Half Year and Second Quarter ...

   www.addexpharma.com › en › investors

   • En cache

   30 sept. 2024 · Addex Therapeutics Reports 2024 Half Year and Second Quarter Financial Results and Provides Corporate Update. Launched Neurosterix with Perceptive Advisors to accelerate the development of M4PAM for schizophrenia; Indivior selected GABA B PAM drug candidate for development in substance use disorders

3. finance.yahoo.com › news › addex-therapeuticsAddex Therapeutics Reports 2024 Half Year and Second Quarter ...

   finance.yahoo.com › news › addex-therapeutics

   • En cache

   30 sept. 2024 · Addex’s lead drug candidate, dipraglurant (mGlu5 negative allosteric modulator or NAM), is under evaluation for future development in brain injury recovery, including post-stroke and traumatic...

4. stockanalysis.com › quote › swxAddex Therapeutics Company Description - Stock Analysis

   stockanalysis.com › quote › swx

   • En cache

   Il y a 6 jours · Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors and enzymes.

   • Exchange: SIX Swiss Exchange
   • Reporting Currency: CHF

   • Fiscal Year: January-December
   • Ticker Symbol: ADXN

5. www.manageo.fr › entreprises › 452688658ENTREPRISE ADDEX PHARMACEUTICALS FRANCE - manageo.fr

   www.manageo.fr › entreprises › 452688658

   • En cache

   3 oct. 2024 · La société ADDEX PHARMACEUTICALS FRANCE, dirigée à ce jour par ADDEX PHARMACEUTICALS LTD représentée par Timothy DYER, a été fondée en mars 2004. C'est donc une entreprise qui bénéficie d'une très forte ancienneté.

   • Lieu: ATHENA 1 ARCHAMPS TECHNOPOLE 72 RUE GEORGES DE MESTRAL 74160 ARCHAMPS

   • Fondateur: ADDEX PHARMACEUTICALS LTD

6. stockanalysis.com › quote › swxAddex Therapeutics Ltd (SWX: ADXN) - Stock Analysis

   stockanalysis.com › quote › swx

   • En cache

   Il y a 6 jours · Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors and enzymes. Its lead programs include Dipraglurant for the treatment of Parkinson’s disease levodopa ...

7. markets.ft.com › data › equitiesAddex Therapeutics Ltd, ADXN:SWX summary - FT.com

   markets.ft.com › data › equities

   • En cache

   Il y a 5 jours · Addex Therapeutics Ltd is a Switzerland-based clinical-stage pharmaceutical company. The Company focuses on development and commercialization of orally available small molecule drugs known as...